SEC Form 4 · accession 0001185185-18-000053
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Exec. Chairman & CEO · Director · 10% Owner
Period of report
Jan 10, 2018
Accepted (ET)
Jan 12, 2018 · 7:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jan 10, 2018 | S | 7,738 | $1.11 | D | 2,384,256 | D | |
| Common stock | Jan 10, 2018 | S | 1,203 | $1.08 | D | 2,383,053 | D | |
| Common stock | Jan 10, 2018 | S | 3,059 | $1.07 | D | 2,379,994 | D | |
| Common stock | Jan 11, 2018 | S | 8,000 | $1.12 | D | 2,371,994 | D | |
| Common stock | Jan 11, 2018 | S | 4,000 | $1.11 | D | 2,367,994 | D | |
| Common stock | Jan 12, 2018 | S | 12,000 | $1.05 | D | 2,355,994 | D |
Table II — derivative securities
No Table II lines on this filing.